canSERVProviding Cutting Edge Cancer Research Services Across Europe
Funding programme: Horizon Europe (N 101058620)
Duration: 3 years (Sept 2022 - Aug 2025)
The canSERV project aims to defragment the landscape of European cancer research and will enable academia and industry access to cross-cutting services and support from basic science up to clinical translation to foster personalised medicine for cancer patients. The project will contribute to the EU Cancer Mission through the provision of innovative services.
All services of the participating infrastructures will be bundled on a common platform. canSERV will connect, coordinate, and align existing oncology and complementary Research Infrastructures (RIs) together providing unified, transnational services. The canSERV project will work to ensure that oncology-related data provided will be fully compliant with the FAIR principles, and complement other relevant EU initiatives.
ECRIN's role in canSERV
ECRIN will be working with other partners to provide clinical investigators in the cancer community with support in the planning and design of complex clinical trials (platform trials, basket trials, umbrella trials, multidisciplinary trials). ECRIN will also develop a secure and GDPR-compliant cancer clinical trial patient-level data sharing repository, based on the model developed in the EOSC-Life project for COVID-19. The tool will focus on linking cancer related data across Europe.